Description
The CJC-1295 + Ipamorelin blend combines two complementary peptides to create a powerful tool for studying dual-pathway GH stimulation. This blend allows researchers to analyze both GHRH-mediated and GHS-mediated growth hormone release simultaneously.
Potential Research Applications
•Synergistic GH Secretion
Used to observe combined effects of GHRH and GHS pathways in controlled models.
•IGF-1 & GH Axis Modulation
Studied for its impact on endocrine and metabolic signaling.
•Regenerative & Cellular Repair Research
Included in research involving tissue recovery, cell regeneration, and anabolic processes.
•Metabolic Function Studies
Explored for its influence on energy regulation and metabolic markers.
Mechanism of Interest
This blend targets two independent pathways involved in GH release:
1.CJC-1295 → GHRH receptor agonism
2.Ipamorelin → Ghrelin/GHS-R1a receptor agonism
Together, they create a dual-stimulation model that allows researchers to observe enhanced GH pulsatility, GH amplitude modulation, and downstream IGF-1 pathway activation, giving insight into synergistic endocrine regulation.
Research Use Only (RUO)
Not for human consumption, medical use, or in vivo application.
Buyer must comply with all research laws and handling standards.